References

Disrupted mitochondrial transcription factor A expression promotes mitochondrial dysfunction and enhances ocular surface inflammation by activating the absent in melanoma 2 inflammasome

10.1016/j.freeradbiomed.2024.05.032 · 2024 · External reference

Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies

10.1016/j.ijpharm.2021.120924 · 2021 · External reference

Potential new target for dry eye disease—oxidative stress

10.3390/antiox13040422 · 2024 · External reference

Precision nutrition based on food bioactive components assisted by delivery nanocarriers for ocular health

10.1016/j.tifs.2025.104923 · 2025 · External reference

Benefits and safety of astaxanthin in the treatment of mild-to-moderate dry eye disease

10.3389/fnut.2021.796951 · 2022 · External reference

An oral polyphenol formulation to modulate the ocular surface inflammatory process and to improve the symptomatology associated with dry eye disease

10.3390/nu14153236 · 2022 · External reference

Orally deliverable lutein nanoparticles as robust ROS scavenger for dry eye disease by targeting Peyer's patches and mitochondria of ocular cell

2024 · External reference

Layer-by-layer oral-deliverable nanoparticles targeted microfold cells to promote lutein absorption in alleviating dry eye disease

2024 · External reference

Resveratrol for dry eye disease – hope or hype?

10.4103/ijo.ijo_3204_22 · 2023 · External reference

The role of resveratrol in eye diseases—A review of the literature

10.3390/nu14142974 · 2022 · External reference

Enhancing the bioavailability of resveratrol: combine It, derivatize It, or encapsulate it?

10.3390/pharmaceutics16040569 · 2024 · External reference

Recent advances in encapsulation of resveratrol for enhanced delivery

10.1016/j.foodchem.2024.140475 · 2024 · External reference

Fabrication of resveratrol-loaded soy protein isolate-glycyrrhizin nanocomplex for improving bioavailability via pH-responsive hydrogel properties

10.1016/j.ijbiomac.2023.128950 · 2024 · External reference

R-Q@P-D nanoparticle for improving the oral bioavailability and therapeutic efficacy: a novel reversible dual-target-mild-inhibition intestinal metabolic enzymes strategy for resveratrol delivery

10.1016/j.cej.2024.154662 · 2024 · External reference

Antioxidant and UV-blocking glucose-crosslinked sericin films with enhanced structural integrity

10.1016/j.reactfunctpolym.2021.104942 · 2021 · External reference

Sericin based nanoformulations: a comprehensive review on molecular mechanisms of interaction with organisms to biological applications

10.1186/s12951-021-00774-y · 2021 · External reference

Versatile inulin/trans-ferulic acid/silk sericin nanoparticles-nourished probiotic complex with prolonged intestinal retention for synergistic therapy of inflammatory bowel disease

10.1016/j.carbpol.2024.123063 · 2025 · External reference

A time-saving ph-ultrasonic-shifting method for insoluble pea protein isolate to encapsulate polyphenol: binding mechanism, structure, and functional characteristics

10.1016/j.foodhyd.2024.110285 · 2024 · External reference

A multitarget synergistic core‐shell nanogel for experimental periodontitis treatment

10.1002/adfm.202420551 · 2025 · External reference

Preparation, characterization, and in vivo evaluation of an oral triptolide nanomatrix system for rheumatoid arthritis therapy

10.3390/pharmaceutics17121567 · 2025 · External reference

Continuous production of antioxidant liposome for synergistic cancer treatment using high-gravity rotating packed bed

10.1016/j.cej.2017.11.143 · 2018 · External reference

Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy

10.1038/s41392-024-01983-1 · 2024 · External reference

Complementary analysis of curcumin biodistribution using optical fluorescence imaging and mass spectrometry

10.1007/s13765-016-0154-y · 2016 · External reference

An insight into the in vivo imaging potential of curcumin analogues as fluorescence probes

2021 · External reference

Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy

10.1016/j.cclet.2022.03.110 · 2022 · External reference

Preparation of curcumin loaded carboxymethyl chitosan nanoparticles and their anti-hepatoma effects through liver-gut circulation

10.1016/j.ijbiomac.2025.145132 · 2025 · External reference

High-efficiency antioxidant ROS-responsive thermosensitive hydrogel encapsulated Fenofibrate for the treatment of corneal neovascularization

10.1016/j.jconrel.2025.113650 · 2025 · External reference

Oral dual-targeted engineered probiotics modulate microbiota and alleviate inflammatory bowel disease via CMV-mediated functional protein delivery

10.1016/j.cej.2025.171857 · 2026 · External reference

dbCAN3: automated carbohydrate-active enzyme and substrate annotation

10.1093/nar/gkad328 · 2023 · External reference

Preparation and characterization of a naringenin solubilizing glycyrrhizin nanomicelle ophthalmic solution for experimental dry eye disease

10.1016/j.ejps.2021.106020 · 2021 · External reference

Heating-driven self-assembled glycyrrhizin nanomicelles loading bisdemethoxycurcumin: preparation, characterization, and efficacy evaluation on experimental dry eye

10.1016/j.colsurfb.2024.114206 · 2025 · External reference

Polymeric nanoparticles as a self‐adjuvanting peptide vaccine delivery system: the role of shape

10.1002/adfm.202209304 · 2023 · External reference

The intracellular fate and transport mechanism of shape, size and rigidity varied nanocarriers for understanding their oral delivery efficiency

10.1016/j.biomaterials.2023.121995 · 2023 · External reference

The effects of polymeric nanostructure shape on drug delivery

10.1016/j.addr.2011.06.016 · 2011 · External reference

Dual strategy for improving the oral bioavailability of resveratrol: enhancing water solubility and inhibiting glucuronidation

10.1021/acs.jafc.1c02602 · 2021 · External reference

Preparation of solid dispersion of Polygonum cuspidatum extract by hot melt extrusion to enhance oral bioavailability of resveratrol

10.3390/molecules28020737 · 2023 · External reference

Lutein encapsulated oleic - linoleic acid nanoemulsion boosts oral bioavailability of the eye protective carotenoid lutein in rat model

2021 · External reference

Polyvinylpyrrolidone-curcumin nanoparticles with immune regulatory and metabolism regulatory effects for the treatment of experimental autoimmune uveitis

10.1016/j.jconrel.2024.06.047 · 2024 · External reference

AMPK/MFF activation: role in mitochondrial fission and mitophagy in dry eye

10.1167/iovs.63.12.18 · 2022 · External reference

Potential role of oxidative stress in ocular surface inflammation and dry eye disease

10.1167/iovs.17-23402 · 2018 · External reference

Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren’s syndrome: a new approach for patient monitoring

10.1177/03946320241263034 · 2024 · External reference

Dual-ROS-scavenging and dual-lingering nanozyme-based eye drops alleviate dry eye disease

10.1186/s12951-024-02499-0 · 2024 · External reference

Amorphous layered double hydroxide-based nano-enzyme eye drops against dry eye disease by inhibiting mitochondrial damage and pyroptosis

10.1186/s12951-025-03727-x · 2025 · External reference

Dry eye disease: oxidative stress on ocular surface and cutting‐edge antioxidants

2025 · External reference

Alleviative effect of probiotics and prebiotics on dry eye in type 2 diabetic mice through the gut-eye axis

10.1016/j.jtos.2025.02.004 · 2025 · External reference

A randomized, double-blind, placebo-controlled study of an anthocyanin-rich functional ingredient on cognitive function and eye dryness in late adulthood volunteers: roles of epigenetic and gut microbiome modulations

10.3390/nu15163499 · 2023 · External reference

Lactoferrin ameliorates dry eye disease potentially through enhancement of short-chain fatty acid production by gut microbiota in mice

10.3390/ijms222212384 · 2021 · External reference

Consumption of Limosilactobacillus fermentum inhibits corneal damage and inflammation in dry eye disease mouse model through regulating the gut microbiome

10.3390/ijms25063528 · 2024 · External reference

Microbiome and immune-mediated dry eye: a review

10.1136/bmjophth-2021-000956 · 2022 · External reference

What is the impact of microbiota on dry eye: a literature review of the gut-eye axis

10.1186/s12886-024-03526-2 · 2024 · External reference

Exploration of the muribaculaceae family in the gut microbiota: diversity, metabolism, and function

10.3390/nu16162660 · 2024 · External reference

The effect of ophthalmic and systemic formulations of Latilactobacillus sakei on clinical and immunological outcomes of patients with dry eye disease: a factorial, randomized, placebo-controlled, and triple-masking clinical trial

10.1007/s12602-023-10079-1 · 2023 · External reference

Oral intake of Streptococcus thermophilus iHA318 mitigates dry eye symptoms in a randomized clinical study

10.3390/biomedicines13040931 · 2025 · External reference

Resveratrol and gut microbiota synergy: preventive and therapeutic effects

10.3390/ijms242417573 · 2023 · External reference

Differential effects of dry eye disorders on metabolomic profile by1H nuclear magnetic resonance spectroscopy

10.1155/2014/542549 · 2014 · External reference

Prostaglandin E2 may clinically alleviate dry eye disease by inducing Th17 cell differentiation

10.1111/cbdd.14477 · 2024 · External reference

Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding

10.1186/s40168-024-01750-y · 2024 · External reference

Resveratrol: its path from isolation to therapeutic action in eye diseases

10.3390/antiox11122447 · 2022 · External reference

Gut microbiota composition in relation to the metabolism of oral administrated resveratrol

10.3390/nu14051013 · 2022 · External reference